Introduction
Being told you have a lung condition can be worrying—especially if it’s something like Mycobacterium avium complex (MAC) lung disease or tuberculosis (TB). Both can affect your lungs, cause a long-lasting cough, and exhibit similar symptoms. Because of this, it’s easy to mix them up. However, they are caused by different bacteria and exhibit distinct behaviours.
Knowing the differences between these two conditions can help you feel more in control when talking with your doctor and making decisions about your care. This article will explain what MAC and TB are, where they come from, who they affect, how they’re diagnosed and treated, and what you can expect if you have either condition.
What Are MAC Lung Disease and Tuberculosis?
MAC lung disease is caused by a group of bacteria known as the Mycobacterium avium complex (MAC), which are commonly found in natural environments such as soil and water. While exposure to these bacteria is frequent, most individuals do not become ill. However, if you have certain health problems or a weak immune system, you might be more likely to develop an infection once the bacteria reach your lungs.1 MAC lung disease typically develops gradually and can cause breathing difficulties over time. This disease isn’t contagious. You cannot catch it from someone else, nor can you pass it on to family members, friends, or colleagues.2
Tuberculosis, or TB, is caused by a different bacteria called Mycobacterium tuberculosis. TB usually affects the lungs, but it can also affect other parts of the body like the spine, brain, or kidneys. Unlike MAC, TB is contagious. It spreads through tiny droplets in the air when someone with active TB coughs, sneezes, or talks. This is why TB is taken very seriously in public health,especially in places where people live close together or don’t have easy access to healthcare.
Not everyone who has the TB bacteria in their body becomes ill. Sometimes, the bacteria stay “asleep” in your system. This is called latent TB. It doesn’t make you feel sick or cause symptoms. But if your immune system becomes weakened, the bacteria can “wake up” and cause active TB, resulting in symptoms.
What Are the Risk Factors?
MAC lung disease affects all ages and genders. People over the age of 65 and women who have been through menopause are at higher risk.3 Other risk factors include smoking, having a weakened immune system, or living with lung problems such as bronchiectasis, chronic obstructive pulmonary disease (COPD), cystic fibrosis, or emphysema. Using antibiotics often or having had lung surgery in the past can also increase your chances of getting MAC.
Alternatively, you may also be at higher risk of being exposed to TB if you live in or travel to countries where TB is more common, such as those in Latin America, the Caribbean, Africa, and Asia. You are also at higher risk if you live in congregational settings such as prisons or refugee camps or if you work in a mycobacteriology laboratory.4 Medical conditions like diabetes or HIV, which weaken the immune system, make it easier for TB to become active.5
Signs and Symptoms
MAC lung disease and TB can cause similar symptoms. These include:
- A cough that doesn’t go away
- Feeling very tired
- Mild fever
- Shortness of breath
- Night sweats
- Losing weight without trying
- Coughing up blood (in some cases)
Even though the symptoms are similar, there are some differences in how they appear. MAC lung disease tends to come on slowly over months or even years. Many people do not realise they are ill until the infection has already caused damage to their lungs. Symptoms can come and go or stay the same for long periods, which can make it hard to spot.6
TB tends to move faster. The symptoms are often more severe and get worse quickly if you don’t get treated. Night sweats and high fevers are more common, and weight loss can happen faster. Because TB progresses quickly, doctors usually act fast if they suspect it.
If you have any of these symptoms for more than a few weeks, it’s important to see your GP. Getting diagnosed early can help protect your lungs and avoid more serious problems.
How Are These Conditions Diagnosed?
To figure out whether you have MAC lung disease or TB, your doctor will need to run a few tests. Some of these tests are the same for both conditions, but there are a few key differences that help tell them apart.
The first step is usually a chest X-ray or a CT scan. These images show what your lungs look like inside. Both MAC and TB can cause changes like small spots (called nodules), cavities, or areas of swelling. However, radiological patterns may differ slightly. MAC often shows up as small spots and widened airways, while TB may cause more severe damage in the upper parts of the lungs.
Sputum tests are another key diagnostic tool. You may be asked to provide mucus that you cough up so it can be tested in the lab. This sample is looked at under a microscope and tested to see which bacteria are present. A key difference here is that MAC bacteria grow very slowly, so it can take weeks to get results. TB bacteria usually grow faster in the lab.
Blood tests can also be useful. There are special tests like the IGRA blood test or the tuberculin skin test that can detect TB. These tests don’t react to MAC bacteria, so they are helpful for ruling out TB rather than confirming MAC.
In more complicated cases, your doctor might suggest a bronchoscopy. This involves inserting a thin tube with a camera into your lungs to collect tissue or fluid samples for analysis. Sometimes, genetic tests are also done on the bacteria to confirm the diagnosis and check if the bacteria are resistant to certain medications.7
How Are These Conditions Treated and Managed?
Treatment
Treating MAC lung disease usually starts with clearing the mucus from your lungs. If this doesn’t work, your doctor may recommend taking a mix of three antibiotics for at least 12 months. These often include azithromycin or clarithromycin (a type of macrolide), ethambutol, and rifampin. Treatment takes a long time because MAC bacteria grow slowly and are harder to get rid of.8
In rare cases, surgery may be needed to remove part of the infected lung if antibiotics do not work. After surgery, you’ll still need to take antibiotics for a short time to make sure any remaining bacteria are gone. If your symptoms are mild or not getting worse, your doctor might wait and monitor you with regular check-ups before starting treatment.
TB is also treated with several antibiotics. Treatment for TB is critical and must be completed fully, even if symptoms improve quickly. Stopping treatment early can lead to drug-resistant TB, which is much harder and more expensive to treat. If you have multidrug-resistant TB (MDR-TB), you may need second-line drugs for up to 18 months or longer.
Common TB medications include:
- Isoniazid (Hyzyd®)
- Rifampin (Rifadin®)
- Ethambutol (Myambutol®)
- Pyrazinamide (Zinamide®)
- Rifapentine (Priftin®)
You might start to feel better and have more energy within a few weeks of starting treatment. But you’ll still need to take your medicine for at least six to nine months to fully clear the infection.
Management
] Long-term management is often necessary for both conditions, as even after successful treatment, the infection can recur. That is why regular check-ups are important. Your doctor may ask you to have follow-up sputum tests and lung scans. Some people might need more than one round of treatment, especially if their lungs are already damaged.9
To help stay well, it’s a good idea to:
- Stop smoking
- Stay up to date with your vaccines
- Eat well and maintain a healthy weight
- Get regular check-ups
Looking after your lungs and your overall health can go a long way in preventing future problems.
Summary
Tuberculosis (TB) and Mycobacterium avium complex (MAC) lung disease can seem similar because they share some symptoms, like coughs and breathlessness. However, they are caused by different bacteria. MAC bacteria live in soil and water and usually do not make healthy people sick. It cannot be transmitted from person to person. People with weak immune systems or lung problems are more at risk. Symptoms of MAC develop slowly over months or years.
TB is caused by a different type of bacterium and is highly contagious. It spreads through the air when someone with the infection coughs or sneezes. TB can stay hidden in the body without symptoms (latent TB) but may become active if the immune system weakens. Active TB symptoms usually come on quickly and are more severe, including fever, night sweats, and weight loss. Doctors use tests like blood samples, sputum tests, and chest scans to tell TB and MAC apart.
Treatment for TB usually lasts six to nine months, while MAC treatment can take over a year. Both need careful follow-up and lifestyle changes, such as quitting smoking. Early diagnosis and treatment help protect your lungs and improve your chances of recovery. Understanding the difference between TB and MAC can help you manage your condition more effectively and communicate better with your healthcare team.
References
- Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large u. S. Managed care health plan, 2008–2015. Annals of the American Thoracic Society. 2020;17(2): 178–185. Available from: https://doi.org/10.1513/AnnalsATS.201804-236OC
- Falkinham JO. Environmental sources of nontuberculous mycobacteria. Clinics in Chest Medicine. 2015;36(1): 35–41. Available from: https://doi.org/10.1016/j.ccm.2014.10.003.
- Chan E, Iseman M. Underlying host risk factors for nontuberculous mycobacterial lung disease. Seminars in Respiratory and Critical Care Medicine. 2013;34(01): 110–123. Available from: https://doi.org/10.1055/s-0033-1333573
- O’Grady J, Maeurer M, Atun R, Abubakar I, Mwaba P, Bates M, et al. Tuberculosis in prisons: anatomy of global neglect. European Respiratory Journal. 2011;38(4): 752–754. Available from: https://doi.org/10.1183/09031936.00041211
- Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. Williams B (ed.) PLoS Medicine. 2008;5(7): e152. Available from: https://doi.org/10.1371/journal.pmed.0050152
- Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest. 2006;129(6): 1653–1672. Available from: https://doi.org/10.1378/chest.129.6.1653
- Larsson LO, Polverino E, Hoefsloot W, Codecasa LR, Diel R, Jenkins SG, et al. Pulmonary disease by non-tuberculous mycobacteria – clinical management, unmet needs and future perspectives. Expert Review of Respiratory Medicine. 2017; 1–13. Available from: https://doi.org/10.1080/17476348.2017.1386563
- Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (Ntm-pd). Thorax. 2017;72(Suppl 2): ii1–ii64. Available from: https://doi.org/10.1136/thoraxjnl-2017-210927
- Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clinics in Chest Medicine. 2015;36(1): 13–34. Available from: https://doi.org/10.1016/j.ccm.2014.10.002

